Vaxart, Inc. Cash and Cash Equivalents, Period Increase (Decrease)
Vaxart, Inc. (VXRT) reported Cash and Cash Equivalents, Period Increase (Decrease) of $9.94 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-06.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-02-06
- Vaxart, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was -$6.42M, a 165.47% decline year-over-year.
- Vaxart, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was -$6.00M, a 415.74% decline year-over-year.
- Vaxart, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-06-30 was $6.43M.
- Vaxart, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-03-31 was $15.92M.
- Vaxart, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2018 was $9.94M.
- Vaxart, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$6.83M.
- Vaxart, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$32.00M, a 740.00% decline from fiscal 2016.
- Vaxart, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2016 was $5.00M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|---|---|
| 2018-12-31 | -$6.42M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06 | -$12.41M derived: sum of 2 quarters · filed 2019-02-06 | -$5.99M derived: sum of 3 quarters · filed 2019-02-06 | $9.94M 10-K · filed 2019-02-06 | ||
| 2018-09-30 | -$6.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $427.00K derived: sum of 2 quarters · filed 2018-11-13 | $16.35M 10-Q · filed 2018-11-13 | $26.15M derived: sum of 4 quarters · filed 2018-11-13 | ||
| 2018-06-30 | $6.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $22.35M 10-Q · filed 2018-08-10 | $32.15M derived: sum of 3 quarters · filed 2018-08-10 | $34.05M derived: sum of 4 quarters · filed 2018-08-10 | ||
| 2018-03-31 | $15.92M 10-Q · filed 2018-05-15 | $25.72M derived: sum of 2 quarters · filed 2018-05-15 | $27.62M derived: sum of 3 quarters · filed 2018-05-15 | $26.92M derived: sum of 4 quarters · filed 2018-08-10 | ||
| 2017-12-31 | $9.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-06 | $11.70M 10-Q · filed 2018-02-06 | $11.00M derived: sum of 3 quarters · filed 2018-08-10 | -$6.83M 10-K · filed 2019-02-06 | ||
| 2017-09-30 | $1.90M 10-Q · filed 2017-11-07 | $1.20M derived: sum of 2 quarters · filed 2018-08-10 | -$6.49M 10-Q · filed 2018-11-13 | -$11.72M derived: sum of 4 quarters · filed 2018-08-10 | ||
| 2017-06-30 | -$700.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | -$5.82M 10-Q · filed 2018-08-10 | -$13.62M derived: sum of 3 quarters · filed 2018-08-10 | -$32.00M 10-K · filed 2017-09-01 | ||
| 2017-03-31 | -$5.12M 10-Q · filed 2018-05-15 | -$12.92M derived: sum of 2 quarters · filed 2018-05-15 | -$37.90M 10-Q · filed 2017-05-08 | $2.38M derived: sum of 4 quarters · filed 2018-05-15 | ||
| 2016-12-31 | -$7.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-06 | -$11.60M 10-Q · filed 2018-02-06 | $7.50M derived: sum of 3 quarters · filed 2018-02-06 | -$900.00K derived: sum of 4 quarters · filed 2018-02-06 | ||
| 2016-09-30 | -$3.80M 10-Q · filed 2017-11-07 | $15.30M derived: sum of 2 quarters · filed 2017-11-07 | $6.90M derived: sum of 3 quarters · filed 2017-11-07 | $600.00K derived: sum of 4 quarters · filed 2017-11-07 | ||
| 2016-06-30 | $19.10M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-01 | $10.70M derived: sum of 2 quarters · filed 2017-09-01 | $4.40M derived: sum of 3 quarters · filed 2017-09-01 | $5.00M 10-K · filed 2017-09-01 | ||
| 2016-03-31 | -$8.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-08 | -$14.70M derived: sum of 2 quarters · filed 2017-05-08 | -$14.10M 10-Q · filed 2017-05-08 | -$30.70M derived: sum of 4 quarters · filed 2017-05-08 | ||
| 2015-12-31 | -$6.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-06 | -$5.70M 10-Q · filed 2017-02-06 | -$22.30M derived: sum of 3 quarters · filed 2017-02-06 | -$21.20M derived: sum of 4 quarters · filed 2017-02-06 | ||
| 2015-09-30 | $600.00K 10-Q · filed 2016-11-08 | -$16.00M derived: sum of 2 quarters · filed 2016-11-08 | -$14.90M derived: sum of 3 quarters · filed 2016-11-08 | -$7.00M derived: sum of 4 quarters · filed 2016-11-08 | ||
| 2015-06-30 | -$16.60M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-13 | -$15.50M derived: sum of 2 quarters · filed 2016-09-13 | -$7.60M derived: sum of 3 quarters · filed 2016-09-13 | -$29.10M 10-K · filed 2016-09-13 | ||
| 2015-03-31 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-10 | $9.00M derived: sum of 2 quarters · filed 2016-05-10 | -$12.50M 10-Q · filed 2016-05-10 | -$11.80M derived: sum of 4 quarters · filed 2016-09-13 | ||
| 2014-12-31 | $7.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-08 | -$13.60M 10-Q · filed 2016-02-08 | -$12.90M derived: sum of 3 quarters · filed 2016-09-13 | $14.50M derived: sum of 4 quarters · filed 2016-09-13 | ||
| 2014-09-30 | -$21.50M 10-Q · filed 2015-11-06 | -$20.80M derived: sum of 2 quarters · filed 2016-09-13 | $6.60M derived: sum of 3 quarters · filed 2016-09-13 | -$1.80M derived: sum of 4 quarters · filed 2016-09-13 | ||
| 2014-06-30 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-13 | $28.10M derived: sum of 2 quarters · filed 2016-09-13 | $19.70M derived: sum of 3 quarters · filed 2016-09-13 | $13.40M 10-K · filed 2016-09-13 | ||
| 2014-03-31 | $27.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-08 | $19.00M derived: sum of 2 quarters · filed 2015-05-08 | $12.70M 10-Q · filed 2015-05-08 | $14.70M derived: sum of 4 quarters · filed 2015-09-11 | ||
| 2013-12-31 | -$8.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-06 | -$14.70M 10-Q · filed 2015-02-06 | -$12.70M derived: sum of 3 quarters · filed 2015-09-11 | -$16.40M derived: sum of 4 quarters · filed 2015-09-11 | ||
| 2013-09-30 | -$6.30M 10-Q · filed 2014-11-07 | -$4.30M derived: sum of 2 quarters · filed 2015-09-11 | -$8.00M derived: sum of 3 quarters · filed 2015-09-11 | $16.90M derived: sum of 4 quarters · filed 2015-09-11 | ||
| 2013-06-30 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-11 | -$1.70M derived: sum of 2 quarters · filed 2015-09-11 | $23.20M derived: sum of 3 quarters · filed 2015-09-11 | $17.80M 10-K · filed 2015-09-11 | ||
| 2013-03-31 | -$3.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-12 | $21.20M derived: sum of 2 quarters · filed 2014-05-12 | $15.80M 10-Q · filed 2014-05-12 | $15.83M 10-Q · filed 2013-05-10 | $13.57M derived: sum of 4 quarters · filed 2014-05-12 | |
| 2012-12-31 | $24.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-10 | $19.50M 10-Q · filed 2014-02-10 | $19.54M 10-Q · filed 2013-02-11 | $17.27M derived: sum of 3 quarters · filed 2014-02-10 | $17.84M derived: sum of 4 quarters · filed 2014-02-10 | |
| 2012-09-30 | -$5.40M 10-Q · filed 2013-11-12 | -$7.63M derived: sum of 2 quarters · filed 2013-11-12 | -$27.99M 10-Q · filed 2012-11-08 | -$5.70M derived: sum of 4 quarters · filed 2013-11-12 | ||
| 2012-06-30 | -$2.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$1.66M 10-Q · filed 2012-08-09 | -$299.00K derived: sum of 3 quarters · filed 2012-08-09 | -$17.60M 10-K · filed 2014-09-30 | ||
| 2012-03-31 | $565.00K 10-Q · filed 2012-05-10 | $1.93M derived: sum of 2 quarters · filed 2012-05-10 | -$19.52M 10-Q · filed 2013-05-10 | $35.78M derived: sum of 4 quarters · filed 2012-08-09 | ||
| 2011-12-31 | $1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-14 | -$13.87M 10-Q · filed 2013-02-11 | $35.22M derived: sum of 3 quarters · filed 2012-08-09 | $40.75M 10-K · filed 2012-03-14 | ||
| 2011-09-24 | $6.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $33.86M derived: sum of 2 quarters · filed 2012-08-09 | $39.38M 10-Q · filed 2012-11-08 | $55.67M derived: sum of 4 quarters · filed 2012-08-09 | ||
| 2011-06-30 | -$34.40M 10-K · filed 2013-09-27 | |||||
| 2011-06-25 | $27.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $33.05M 10-Q · filed 2012-08-09 | $49.34M derived: sum of 3 quarters · filed 2012-08-09 | $54.16M derived: sum of 4 quarters · filed 2012-08-09 | ||
| 2011-03-26 | $5.53M 10-Q · filed 2012-05-10 | $21.81M derived: sum of 2 quarters · filed 2012-05-10 | $26.64M derived: sum of 3 quarters · filed 2012-05-10 | |||
| 2010-12-25 | $16.28M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-14 | $21.11M derived: sum of 2 quarters · filed 2012-03-14 | -$5.95M 10-K · filed 2012-03-14 | |||
| 2010-09-25 | $4.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | -$22.23M 10-Q · filed 2011-11-02 | ||||
| 2010-06-26 | -$27.06M 10-Q · filed 2011-08-03 | |||||
| 2009-12-26 | -$46.93M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |